Summary Safety Review - Lanoxin, Toloxin, Apo-digoxin, PMS-digoxin, (Digoxin) - Assessing the Potential Higher Risk of Death Compared to Patients not Using Digoxin (French, HTML)
View metadata and access the original French HTML file: Summary Safety Review - Lanoxin, Toloxin, Apo-digoxin, PMS-digoxin, (Digoxin) - Assessing the Potential Higher Risk of Death Compared to Patients not Using Digoxin.
- Format
- HTML
- Access
- file-only
- Publisher-reported update
- 2024-05-09
Health Canada completed a safety review to evaluate if using digoxin was linked to a higher risk of death compared to patients not using digoxin. Results of the studies suggested that digoxin use may be linked with a higher risk of death when compared to patients not using digoxin, especially among patients diagnosed with an irregular heart rhythm.
Data overview
- Formats
- HTML
- File languages
- French
- Available actions
- Access original file